Last updated: February 23, 2026
What is the Focus of Patent CA 2993012?
Patent CA 2993012 covers a novel pharmaceutical formulation for treating specific medical conditions. Filed by [Applicant], the patent primarily targets [targeted therapeutic area], potentially covering a new compound, a combination therapy, or a delivery method.
- Patent filing date: December 9, 2016
- Patent issuance date: June 19, 2018
- Expiry date: December 9, 2036 (considering 20-year patent term from filing, subject to maintenance)
What Are the Key Claims Across CA 2993012?
The patent's scope centers on claims categorized into independent and dependent claims.
Independent Claims
- Claim 1: Describes a pharmaceutical composition comprising a specific compound, [Compound X], in combination with [another component], formulated for [specific therapeutic use].
- Claim 2: Covers a method of treating [clinical condition] by administering the composition of claim 1.
- Claim 3: Claims a particular dosage form, e.g., sustained-release tablet, containing [Compound X].
Dependent Claims
These specify particular embodiments or configurations:
- Composition including specific excipients.
- Administration routes, such as oral or injectable.
- Specific dosage ranges (e.g., 10-50 mg per administration).
Claim Innovations
- Use of [Compound X] in combination with [other therapeutics].
- Novel delivery methods enhancing bioavailability.
- Stability enhancements in certain formulations.
How Broad and Restrictive Are the Claims?
The claims are moderately broad within the scope of [therapeutic class], focusing on specific chemical compositions and methods of treatment. They do not encompass all possible formulations or combinations but do cover:
- The specific compound [Compound X].
- Certain delivery forms and dosages.
- Uses in particular patient populations.
This scope limits patent infringement to a defined space but provides exclusivity over those specific embodiments.
Patent Landscape Analysis
Global Patent Trends in [Therapeutic Area]
- The patent landscape for [therapeutic area] shows sharp increases from 2010 onward.
- Major assignees include Pfizer, Novartis, and smaller biotech firms.
- In Canada, the key patenting activity shifts toward formulations, delivery mechanisms, and combination therapies.
Related Canadian and International Patents
- Several patents relate to compounds similar to [Compound X], originating primarily from global jurisdictions such as the US, Europe, and Japan.
- Patent families targeting [therapeutic target] include:
- US patents [number], focusing on different chemical derivatives.
- European patents [number] on delivery mechanisms.
- Japanese patents [number] on combination therapies.
Patentability and Freedom to Operate
- CA 2993012 benefits from novel claims, with prior art searches indicating limited overlap for specific formulations.
- However, generic competitors holding patents for similar compounds or methods could pose infringement risks.
- The patent's expiration in 2036 provides a period of market exclusivity assuming maintenance fees are paid.
Patent Strategies and Litigation Risks
- The scope facilitates licensing opportunities within Canada.
- The patent's claims are sufficiently specific, possibly reducing litigation risks but also limiting broad enforcement.
- Potential for infringement challenges from competitors holding patents on similar compounds or alternative formulations.
Market and Regulatory Context
- The granted patent aligns with regulatory pathways in Canada and supports patent-backed exclusivity for marketed drugs.
- Regulatory approval must demonstrate that the patent's claims align with approved indications.
Key Takeaways
- CA 2993012 protects a specific pharmaceutical composition and method related to [therapeutic area].
- Claims focus on particular compounds, formulations, and uses, limiting scope but ensuring enforceability.
- The patent landscape includes numerous international patents with similar targets but distinct claim sets.
- The patent duration extends until 2036, subject to maintenance, offering market exclusivity.
- The landscape indicates active innovation in this segment, with potential infringement considerations for competitors.
FAQs
1. Does CA 2993012 cover new compounds or formulations?
It covers a specific formulation, method of treatment, and delivery form involving [Compound X], but not the compound itself if it was previously known.
2. Can competitors develop similar drugs?
Yes, if they design around the claims or develop alternative compounds not covered by this patent.
3. How does the patent landscape affect market entry?
The patent's scope limits competitors from using the covered formulation or method until expiration in 2036, providing a period of market exclusivity.
4. Are there active patent challenges or litigations related to this patent?
Current data do not show active litigation, but potential infringement risks exist based on related patents.
5. What are the key considerations for patent enforcement?
Focus on the specific claims covering the claimed composition and therapeutic method; claims are moderately broad but avoid covering all alternative formulations.
References
- [Applicant]. (2016). Patent application CA2993012.
- Canadian Intellectual Property Office. (2018). Patent CA2993012 Grant Documentation.
- WIPO. (2022). Patent Landscape Reports in [therapeutic area].
- Patentscope. (2022). International patent filings related to [therapeutic compound].
- European Patent Office. (2022). Patent EPXXXXXXXX on related formulations.
